Pharmaceutical Commerce | Page 1

Featured Content

Click here to read the articles and download the PDF

Pharmaceutical Commerce - October 2022

Click here to read the articles and download the PDF

Betting the House on Orphan Drugs

While all drug development efforts are fraught with peril, a growing number of biopharma companies—large and small—are staking a claim in the rare disease treatment space, chasing odds that could yield clinical and financial rewards

Cold Chain Tech Continues to Evolve

The pandemic, which stressed all participants in the pharma cold chain, has not stopped innovation in industry practices, as exploration of the main drivers shows

Global Logistics: A Cold Chain Blueprint

The growing pipeline of cold chain products holds tremendous promise for patients, but can result in failed shipments if not properly planned for

WuXi STA Unveils New Parenteral Formulation Manufacturing Line

December 05, 2022

Will further boost CDMO’s injectable drug product platform

Merck, BigHat BioSciences Collaborate on Drug Discovery Programs

December 02, 2022

Biotech company’s AI/machine learning-enabled platform to design candidates for up to three drug discovery programs

People Spotlight — November 2022

November 30, 2022

The latest people news happenings over the past month

Etihad Cargo Awarded CEIV Pharma Certification

November 29, 2022

UAE-based carrier earns recertification based on its compliance to pharma regulations

Sanofi Settles into New Paris HQ

November 28, 2022

Site promotes environmental sustainability

Veeva Releases New Digital Engagement Data

November 23, 2022

Report shows US healthcare professional access approaching 80% in ‘key specialties’

Advancing PV Operations and Patient Safety through Innovation

November 22, 2022

How digital adoption is driving pharmacovigilance

Schreiner MediPharm, SCHOTT Introduce Prefilled Syringes Powered by RFID Labels

November 21, 2022

Can help facilitate digital identification of medications

MilliporeSigma Commits $286 Million toward US Biosafety Testing

November 18, 2022

Drug safety analysis to be conducted at Rockland, MD facility

Disrupting the Pharmaceutical Industry

November 17, 2022

A Harvard Business School Healthcare Alumni Association C-suite Q&A with Mark Cuban, Cost Plus Drugs co-founder